1) Test footnote
HDAC inhibitor (topical)
HDAC inhibitor (topical)
Cutaneous T-cell lymphoma (MF)1)
Phase II
Basal cell carcinoma
Phase I
test
Market
SMAC mimetic (intravenous)
SMAC mimetic (Intravenous)
Solid tumors (Keytruda® combination)
Phase I
Cathepsin K inhibitor (oral)
Cathepsin K inhibitor
Osteoarthritis
Phase II
1) Test footnote
Nucleotide NS5B polymerase inhibitor
Nucleotide NS5B polymerase inhibitor
Hepatitis C - Phase I
Preclinical
Hydrocortisone and aciclovir combination
Hydrocortisone and aciclovir combination
Labial herpes
Market